• Mortality Risk in Oropharynx Cancer Varies Based on HPV Status drugs
    January 20, 2020
    For patients with oropharynx cancer, the rates of head and neck cancer (HNC) mortality and competing mortality vary depending on human papillomavirus (HPV) status, with increased risks for HNC mortality and competing mortality in HPV-negative patients ...
PharmaSources Customer Service